Сърдечносъдовите (СС) нежелани реакции, в частност аритмиите, изглежда са свързани най - о
ori Cardiovascular (CVS) adverse events, particularly arrhythmia, appeared to be correlated mostly with pre- existing CVS disease and prior therapy with cardiotoxic agents (see section 4.4).